Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 175 participants.
Also called NCT03603912
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 175 participants
- Registry
-
NCT03603912
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03603912. Randomized; single masking; primary purpose treatment. Start 2018-08-24 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)
- Acronym
- TRIM-AF
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Metformin
- Intervention (Behavioral)
- Lifestyle/Risk Factor Modification
- Lead sponsor
- Mina Chung, MD
- Collaborator
- American Heart Association
- Collaborator
- The Cleveland Clinic
Record details
- Record id
cardio:ct-nct03603912- Content hash
559f127b231480a14a7b49edae30461e82412fc7ee417d7401c69228942ab3e3